Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies

Vaccine

Volumn 29, Issue 25, 2011, Pages 4195-4201

  Wu, Xianfu ^a   Franka, Richard ^a   Henderson, Heather ^a   Rupprecht, Charles E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Attenuated rabies virus ERAg3m; Co infection; Pre exposure prophylaxis; Rabies; Rabies vaccination regimen

Indexed keywords

INACTIVATED VACCINE; LIVE ATTENUATED RABIES VIRUS ERAG3M; MATRIX PROTEIN; RABIES VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS; SURVIVAL; SYRIAN HAMSTER; VACCINATION; VIRUS GENE; VIRUS GENOME;

ANIMALS; CRICETINAE; FEMALE; INJECTIONS, INTRAMUSCULAR; MESOCRICETUS; MICE; MICE, INBRED ICR; RABIES; RABIES VACCINES; RABIES VIRUS; SURVIVAL ANALYSIS; VACCINATION; VACCINES, ATTENUATED;

EID: 79956205899     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.104     Document Type: Article

References (45)

1. Iwai M., Takizawa T., Nakayama T., Matsuura K., Yoshida H., Hasequwa S., et al. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Scand J Infect Dis 2008, 40:247-253.
2. Shinjoh M., Miyairi I., Hoshino K., Takahashi T., Nakayama T. Effective and safe immunization with live-attenuated vaccines for children after living donor liver transplantation. Vaccine 2008, 26:6859-6863.
3. Dhillon S., Curran M.P. Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra). Pediatr Drugs 2008, 10:337-347.
4. Jennings R., Green T., Kinghorn G.R. Herpesvirus vaccines: an update. BioDrugs 1998, 10:257-264.
5. Sohn Y.M., Tandan J.B., Yoksan S., Ji M., Ohrr H. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses. Vaccine 2008, 26:1638-1643.
6. Martins M.A., Silva M.L., Elói-Santos S.M., Ribeiro J.G., Peruhype-Magalhães V., Marciano A.P., et al. Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17D live attenuated yellow fever first-time vaccination. Vaccine 2008, 26:1173-1184.
7. Rupprecht C.E., Briggs D., Brown C.M., Franka R., Katz S.L., Herr H.D., et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010, 59(RR-2):1-9.
8. McLimans W.F., Davis E.V., Glover F.L., Rake G.W. The submerged culture of mammalian cells: the spinner culture. J Immunol 1957, 79:428-433.
9. Petricciani J., Sheets R. An overview of animal cell substrate for biological products. Biologicals 2008, 36:359-362.
10. Wiktor T.J., Fernandes M.V., Koprowski H. Cultivation of rabies virus in human diploid cell strain WI-38. J Immunol 1964, 93:353-366.
11. Wu X., Rupprecht C.E. Glycoprotein gene relocation in rabies virus. Virus Res 2008, 131:95-99.
12. Wu X., Franka R., Velasco-Villa A., Rupprecht C.E. Are all lyssavirus genes equal for phylogenetic analyses?. Virus Res 2007, 129:91-103.
13. Wu X., Gong X., Foley H.D., Schnell M.J., Fu Z.F. Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated. J Virol 2002, 76:4153-4161.
14. Wang Z.W., Sarmento L., Wang Y., Li X.Q., Dhingra V., Tseggai T., et al. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 2005, 79:12554-12565.
15. Lafon M. Immune evasion, a critical strategy for rabies virus. Dev Biol (Basel) 2008, 131:413-419.
16. Koprowski L., Black J. Studies on chick embryo adapted rabies virus. V. Protection of animals with antiserum and living attenuated virus after exposure to street strain of rabies virus. J Immunol 1954, 72:85-93.
17. Franka R., Wu X., Jackson F.R., Velasco-Villa A., Palmer D.P., Henderson H., et al. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies viruses. Vaccine 2009, 27:7149-7155.
18. Who goes first? The story of self-experimentation in medicine 1998, 92-126. University of California Press. 1st ed. L.K. Altman (Ed.).
19. Koprowski L., Cox H.R. Recent developments in the prophylaxis of rabies. Am J Public Health 1951, 41:1483-1489.
20. World Health Organization Technical Report Series. No. 82, Expert Committee on Rabies, 2nd Report, April 1954:1-27.
21. Coons A.H., Creech H.J., Jones R.N. Immunological properties of an antibody-containing fluorescent group. Proc Soc Exp Biol Med 1941, 47:200-202.
22. Chabala S., Williams M., Amenta R., Ognjan A.F. Confirmed rabies exposure during pregnancy: treatment with human rabies globulin and human diploid cell vaccine. Am J Med 1991, 91:423-424.
23. Sudarshan M.K., Madhusudana S.N., Mahendra B.J. Post-exposure prophylaxis with purified vero cell vaccine during pregnancy-safety and immunogenicity. J Commun Dis 1999, 31:229-236.
24. Sudarshan M.K., Giri M.S., Mahendra B.J., Venkatesh G.M., Sanjay T.V., Narayana D.H., et al. Assessing the safety of post-exposure rabies immunization in pregnancy. Hum Vaccine 2007, 3:87-89.
25. Sampath G., Parikh, Sangram P., Briggs D.J. Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals. Vaccine 2005, 23:1102-1105.
26. Chulasugandha P., Khawplod P., Havanond P., Wilde H. Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children. Vaccine 2006, 24:1478-1482.
27. Ajjan N., Pilet C. Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells. Vaccine 1989, 7:125-128.
28. Arai Y.T., Montalban C.S. Comparative studies on chick embryo cell rabies vaccine and human diploid cell vaccine: pre-exposure use and purity of the vaccines. Southeast Asian J Trop Med Public Health 1993, 24:747-750.
29. Dietzschold B., Hooper D.C. Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV). Vaccine 1998, 16:1656-1659.
30. Sabchareon A., Lang J., Attanath P., Sirivichayakul C., Pengsaa K., Mener V., et al. A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children. Clin Infect Dis 1999, 29:141-149.
31. Jones R.L., Froeschle J.E., Atmar R.L., Matthew J.S., Sanders R., Pardalos J., et al. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 2001, 19:4635-4643.
32. Koprowski L., Cox H.R. Studies on chick embryo adapted rabies virus. I. Culture characteristics and pathogenicity. J Immunol 1948, 60:533-554.
33. Koprowski L., Black J. Studies on chick embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purpose. J Immunol 1950, 64:185-196.
34. Koprowski L., Black J. Studies on chick embryo adapted rabies virus. IV. Immunization of Guinea-pigs and description of a potency control test. J Immunol 1954, 72:79-84.
35. Koprowski L., Black J., Nelsen D.J. Studies on chick embryo adapted rabies virus. VI. Further changes in pathogenic properties following prolonged cultivation in the developing chick embryo. J Immunol 1954, 72:94-106.
36. Koprowski L., Black J. Studies on chick embryo adapted rabies virus. VII. Immunological responses of animals to vaccination with high egg passage Flury strain. J Immunol 1954, 72:503-510.
37. Abelseth M.K. Further studies on the use of ERA rabies vaccine in domestic animals. Can Vet J 1967, 8:221-227.
38. Fehlner-Gardiner C., Nadin-Davis S., Armstrong J., Muldoon F., Bachmann P., Wandeler A. ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario Canada, 1989-2004. J Wildl Dis 2008, 44:71-85.
39. Mark R.E., Young J. Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology. J Neuropathol Exp Neurol 1994, 53:1-10.
40. Tirawatnpong S., Hemachudha T., Sathaporn M., Shuangshoti S., Phanthumchinda K., Phanuphak P. Regional distribution of rabies viral antigens in central nervous system of human encephalitic and paralytic rabies. J Neurol Sci 1989, 92:91-99.
41. Moore S.M., Wilkerson M.J., Davis R.D., Wyatt C.R., Briggs D.J. Detection of cellular immunity to rabies antigens in human vaccinees. J Clin Immunol 2006, 26:533-545.
42. Smith J.S., McCelland C.L., Reid F.L., Baer G.M. Dual role of the immune responses in street rabies virus infection of mice. Infect Immun 1982, 35:213-221.
43. Galelli A., Baloul L., Lafon M. Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis. J Neurovirol 2000, 6:359-372.
44. Lambot M., Blasco E., Barrat J., Cliquet F., Brochier B., Renders C., et al. Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG-2 and V-RG vaccines. Vaccine 2001, 19:1827-1835.
45. Lawson K.F., Chiu H., Crosqrey S.J., Matson M., Casey G.A., Campbell J.B. Duration of immunity in foxes vaccinated orally with ERA vaccine in a bait. Can J Vet Res 1997, 61:39-42.